NCT01296204View on ClinicalTrials.gov

Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

Not specified

Conditions
Multiple Myeloma
Interventions
DRUG

BB4 antibody-Iodine 131

Injection of an antibody after labelling with Iodine 131

Trial Locations (2)

44805

Centre René Gauducheau, Nantes

Unknown

Moreau, Nantes

All Listed Sponsors
lead

Centre René Gauducheau

OTHER

NCT01296204 - Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131 | Biotech Hunter | Biotech Hunter